A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their ...

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 ...

Researchers reviewed evidence linking GLP-1 and GLP-1 receptor agonists to chronic pain modulation through gut microbial, ...

"Eighty-four percent of households with GLP-1 users visit McDonald's. This is an opportunity," McDonald's USA president Skye ...

Dozens of lawsuits claim the drugs led to vision loss, though evidence is mixed.

The FDA took issue with the volume of GLP-1 drugs that Empower produces, suggesting in the warning letter that the changes do ...

Some of the companies that produce GLP-1 drugs like Ozempic and Zepbound are facing lawsuits as patients allege that the drugs caused permanent eye damage. They claim that makers of the drugs should ...

Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country's biggest ...

Patients filed lawsuits against manufacturers of GLP-1 medications, including Ozempic and Wegovy, alleging the drugs caused non-arteritic anterior ischemic optic neuropathy and permanent vision loss.

Illinois Gov. JB Pritzker revealed to "CBS Mornings" that for the last two years he has been using a GLP-1 medication to lose weight.

McDonald's is considering new protein-based products to win over GLP-1 drug users and says that many of its current items are ...

She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. Here’s what ...